Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 3 | 2024 | 2127 | 1.040 |
Why?
|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2024 | 37 | 0.900 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2024 | 517 | 0.720 |
Why?
|
Postpartum Period | 2 | 2024 | 1168 | 0.700 |
Why?
|
Progestins | 1 | 2018 | 303 | 0.550 |
Why?
|
Influenza Vaccines | 1 | 2024 | 770 | 0.540 |
Why?
|
Obstetrics | 1 | 2023 | 668 | 0.520 |
Why?
|
HIV Infections | 5 | 2024 | 17159 | 0.520 |
Why?
|
Qualitative Research | 1 | 2024 | 2958 | 0.440 |
Why?
|
Pregnancy, Ectopic | 1 | 2014 | 143 | 0.430 |
Why?
|
Prenatal Care | 1 | 2020 | 1128 | 0.410 |
Why?
|
Vaccination | 1 | 2024 | 3360 | 0.390 |
Why?
|
Postnatal Care | 2 | 2024 | 260 | 0.380 |
Why?
|
Puerperal Disorders | 2 | 2024 | 300 | 0.360 |
Why?
|
Patient Readmission | 1 | 2024 | 3327 | 0.340 |
Why?
|
Pregnancy | 9 | 2024 | 29725 | 0.340 |
Why?
|
Cicatrix | 1 | 2014 | 781 | 0.320 |
Why?
|
Disease Management | 1 | 2019 | 2508 | 0.310 |
Why?
|
Premature Birth | 1 | 2018 | 1771 | 0.270 |
Why?
|
Cesarean Section | 1 | 2014 | 1386 | 0.260 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3381 | 0.210 |
Why?
|
Pregnancy, High-Risk | 1 | 2020 | 119 | 0.170 |
Why?
|
Home Childbirth | 1 | 2020 | 55 | 0.170 |
Why?
|
Pregnancy Trimester, Third | 1 | 2022 | 582 | 0.170 |
Why?
|
Gynecology | 1 | 2023 | 534 | 0.140 |
Why?
|
Interviews as Topic | 1 | 2024 | 2656 | 0.140 |
Why?
|
Physicians, Primary Care | 1 | 2023 | 624 | 0.130 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2020 | 1349 | 0.130 |
Why?
|
Internal Medicine | 1 | 2023 | 1045 | 0.130 |
Why?
|
Female | 11 | 2024 | 391011 | 0.120 |
Why?
|
Influenza, Human | 1 | 2024 | 1532 | 0.100 |
Why?
|
Patient Care Team | 1 | 2023 | 2510 | 0.100 |
Why?
|
Carcinoma, Endometrioid | 1 | 2014 | 276 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1208 | 0.090 |
Why?
|
Cohort Studies | 3 | 2024 | 41317 | 0.090 |
Why?
|
Viral Load | 1 | 2020 | 3323 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2019 | 1780 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2906 | 0.080 |
Why?
|
Social Support | 1 | 2019 | 2145 | 0.080 |
Why?
|
Humans | 12 | 2024 | 760261 | 0.080 |
Why?
|
Hysterectomy | 1 | 2014 | 901 | 0.080 |
Why?
|
Video Recording | 1 | 2014 | 957 | 0.080 |
Why?
|
Retrospective Studies | 4 | 2022 | 80301 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5876 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2018 | 1939 | 0.070 |
Why?
|
Adult | 5 | 2024 | 219847 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5507 | 0.070 |
Why?
|
Logistic Models | 1 | 2021 | 13311 | 0.070 |
Why?
|
Primary Health Care | 1 | 2023 | 4649 | 0.070 |
Why?
|
Insurance, Health | 1 | 2018 | 2500 | 0.070 |
Why?
|
United States | 3 | 2024 | 72363 | 0.070 |
Why?
|
Massachusetts | 1 | 2018 | 8805 | 0.060 |
Why?
|
Faculty, Medical | 1 | 2014 | 1192 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2014 | 1361 | 0.060 |
Why?
|
Hypertension | 1 | 2023 | 8595 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Ultrasonography | 1 | 2014 | 5960 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2021 | 26168 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8621 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4786 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 58673 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9274 | 0.030 |
Why?
|
Internship and Residency | 1 | 2014 | 5867 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 933 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2019 | 64947 | 0.030 |
Why?
|
Counseling | 1 | 2020 | 1550 | 0.030 |
Why?
|
Education | 1 | 2014 | 535 | 0.020 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2014 | 517 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10552 | 0.020 |
Why?
|
Risk | 1 | 2014 | 9629 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8553 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11141 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24086 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11480 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20048 | 0.010 |
Why?
|
Aged | 1 | 2014 | 168995 | 0.000 |
Why?
|
Middle Aged | 1 | 2014 | 220175 | 0.000 |
Why?
|
Concepts
(78)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_